A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX
Clinical trial NCT03450018 · TERMINATED
Trial details
- NCT number
- NCT03450018
- Sponsor
- British Columbia Cancer Agency
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-10
- Primary completion
- 2024-05-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.